Global Artificial Lung Market Overview:
Global Artificial Lung Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Artificial Lung Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Artificial Lung involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Lung Market:
The Artificial Lung Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Artificial Lung Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Lung Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Artificial Lung market has been segmented into:
Extracorporeal Membrane Oxygenation
Ventilator Support Systems
Implantable Artificial Lungs
By Application, Artificial Lung market has been segmented into:
Respiratory Failure
Lung Transplantation
Cardiac Support
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Lung market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Lung market.
Top Key Players Covered in Artificial Lung market are:
Abbott Laboratories
Asahi Kasei Corporation
Xenios AG
LivaNova
Baxter International
Nipro Corporation
Getinge AB
Air Products and Chemicals
Sangart
Tandem Diabetes Care
Cleveland Clinic
C3S
Terumo Corporation
Fresenius Medical Care
Medtronic
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Artificial Lung Market Type
4.1 Artificial Lung Market Snapshot and Growth Engine
4.2 Artificial Lung Market Overview
4.3 Extracorporeal Membrane Oxygenation
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Extracorporeal Membrane Oxygenation: Geographic Segmentation Analysis
4.4 Ventilator Support Systems
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Ventilator Support Systems: Geographic Segmentation Analysis
4.5 Implantable Artificial Lungs
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Implantable Artificial Lungs: Geographic Segmentation Analysis
Chapter 5: Artificial Lung Market Application
5.1 Artificial Lung Market Snapshot and Growth Engine
5.2 Artificial Lung Market Overview
5.3 Respiratory Failure
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Respiratory Failure: Geographic Segmentation Analysis
5.4 Lung Transplantation
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Lung Transplantation: Geographic Segmentation Analysis
5.5 Cardiac Support
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Cardiac Support: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Artificial Lung Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 ASAHI KASEI CORPORATION
6.4 XENIOS AG
6.5 LIVANOVA
6.6 BAXTER INTERNATIONAL
6.7 NIPRO CORPORATION
6.8 GETINGE AB
6.9 AIR PRODUCTS AND CHEMICALS
6.10 SANGART
6.11 TANDEM DIABETES CARE
6.12 CLEVELAND CLINIC
6.13 C3S
6.14 TERUMO CORPORATION
6.15 FRESENIUS MEDICAL CARE
6.16 MEDTRONIC
Chapter 7: Global Artificial Lung Market By Region
7.1 Overview
7.2. North America Artificial Lung Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Extracorporeal Membrane Oxygenation
7.2.2.2 Ventilator Support Systems
7.2.2.3 Implantable Artificial Lungs
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Respiratory Failure
7.2.3.2 Lung Transplantation
7.2.3.3 Cardiac Support
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Artificial Lung Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Extracorporeal Membrane Oxygenation
7.3.2.2 Ventilator Support Systems
7.3.2.3 Implantable Artificial Lungs
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Respiratory Failure
7.3.3.2 Lung Transplantation
7.3.3.3 Cardiac Support
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Artificial Lung Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Extracorporeal Membrane Oxygenation
7.4.2.2 Ventilator Support Systems
7.4.2.3 Implantable Artificial Lungs
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Respiratory Failure
7.4.3.2 Lung Transplantation
7.4.3.3 Cardiac Support
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Artificial Lung Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Extracorporeal Membrane Oxygenation
7.5.2.2 Ventilator Support Systems
7.5.2.3 Implantable Artificial Lungs
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Respiratory Failure
7.5.3.2 Lung Transplantation
7.5.3.3 Cardiac Support
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Artificial Lung Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Extracorporeal Membrane Oxygenation
7.6.2.2 Ventilator Support Systems
7.6.2.3 Implantable Artificial Lungs
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Respiratory Failure
7.6.3.2 Lung Transplantation
7.6.3.3 Cardiac Support
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Artificial Lung Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Extracorporeal Membrane Oxygenation
7.7.2.2 Ventilator Support Systems
7.7.2.3 Implantable Artificial Lungs
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Respiratory Failure
7.7.3.2 Lung Transplantation
7.7.3.3 Cardiac Support
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Artificial Lung Scope:
|
Report Data
|
Artificial Lung Market
|
|
Artificial Lung Market Size in 2025
|
USD XX million
|
|
Artificial Lung CAGR 2025 - 2032
|
XX%
|
|
Artificial Lung Base Year
|
2024
|
|
Artificial Lung Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Asahi Kasei Corporation, Xenios AG, LivaNova, Baxter International, Nipro Corporation, Getinge AB, Air Products and Chemicals, Sangart, Tandem Diabetes Care, Cleveland Clinic, C3S, Terumo Corporation, Fresenius Medical Care, Medtronic.
|
|
Key Segments
|
By Type
Extracorporeal Membrane Oxygenation
Ventilator Support Systems
Implantable Artificial Lungs
By Applications
Respiratory Failure
Lung Transplantation
Cardiac Support
|
